adynovate 250iu powder and solvent for solution for injection
takeda malaysia sdn bhd - rurioctocog alfa pegol -
adynovate 500iu powder and solvent for solution for injection
takeda malaysia sdn bhd - rurioctocog alfa pegol -
adynovate 750iu powder and solvent for solution for injection
takeda malaysia sdn bhd - rurioctocog alfa pegol -
nuwiq, human cell line recombinant human factor viii (human-cl rhfviii) 4000 iu powder and solvent for solution for injection. vial of powder and prefilled wfi syringe
octapharma australia pty ltd - simoctocog alfa, quantity: 4000 iu - injection, powder for - excipient ingredients: poloxamer; arginine hydrochloride; sucrose; sodium chloride; sodium citrate dihydrate; calcium chloride dihydrate - treatment and prophylaxis of bleeding (also during and after surgery) in previously treated paediatric (>= 2 years) and adult patients with haemophilia a (congenital factor viii deficiency). nuwiq does not contain von willebrand factor and is thus not indicated to treat von willebrand?s disease.
nuwiq, human cell line recombinant human factor viii (human-cl rhfviii) 3000 iu powder and solvent for solution for injection. vial of powder and prefilled wfi syringe
octapharma australia pty ltd - simoctocog alfa, quantity: 3000 iu - injection, powder for - excipient ingredients: poloxamer; arginine hydrochloride; sucrose; sodium chloride; sodium citrate dihydrate; calcium chloride dihydrate - treatment and prophylaxis of bleeding (also during and after surgery) in previously treated paediatric (>= 2 years) and adult patients with haemophilia a (congenital factor viii deficiency). nuwiq does not contain von willebrand factor and is thus not indicated to treat von willebrand?s disease.
nuwiq, human cell line recombinant human factor viii (human-cl rhfviii) 2500 iu powder and solvent for solution for injection. vial of powder and prefilled wfi syringe
octapharma australia pty ltd - simoctocog alfa, quantity: 2500 iu - injection, powder for - excipient ingredients: poloxamer; arginine hydrochloride; sucrose; sodium chloride; sodium citrate dihydrate; calcium chloride dihydrate - treatment and prophylaxis of bleeding (also during and after surgery) in previously treated paediatric (>= 2 years) and adult patients with haemophilia a (congenital factor viii deficiency). nuwiq does not contain von willebrand factor and is thus not indicated to treat von willebrand?s disease.
nuwiq 250 iu injection
octapharma south africa (pty) ltd - injection - see ingredients - each vial contains simoctocog alfa, coagulation factor viii 250,0 iu
nuwiq 500 iu injection
octapharma south africa (pty) ltd - injection - see ingredients - each vial contains simoctocog alfa, coagulation factor viii 500,0 iu
nuwiq 1 000 iu injection
octapharma south africa (pty) ltd - injection - see ingredients - each vial contains simoctocog alfa, coagulation factor viii 1 000,0 iu
nuwiq 2 000 iu injection
octapharma south africa (pty) ltd - injection - see ingredients - each vial contains simoctocog alfa, coagulation factor viii 2 000,0 iu